KR890001851B1 - Process for the preparation of amine alkanolester - Google Patents
Process for the preparation of amine alkanolester Download PDFInfo
- Publication number
- KR890001851B1 KR890001851B1 KR1019850002939A KR850002939A KR890001851B1 KR 890001851 B1 KR890001851 B1 KR 890001851B1 KR 1019850002939 A KR1019850002939 A KR 1019850002939A KR 850002939 A KR850002939 A KR 850002939A KR 890001851 B1 KR890001851 B1 KR 890001851B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- reaction
- ester
- carbon atoms
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
본 발명은 위장 근육 조직의 경련과 연동을 억제하는데 유효한 구조식(I)의 아미노알칸올에스테르 유도체의 신구 제조방법에 관한 것이다.The present invention relates to a method for producing new and old aminoalkanol ester derivatives of formula (I), which is effective for inhibiting spasms and peristalsis of gastrointestinal muscle tissue.
상기 구조식에서, R1은 수소, 탄소수 1 내지 4의 알킬, 탄소수 1내지 4의 알콕실, 할로겐, 트리플루오로메틸기를 의미하며, R2는 수소, 탄소수 1내지 4의 알킬기를 의미하고, R3내지 R7은 서로 같거나 다른 탄소수 1내지 4의 알킬기를 의미하고, X,Y,Z는 각각 0 또는 1을 의미하고, n은 1 내지 3의 정수를 의미한다.In the above formula, R 1 means hydrogen, alkyl of 1 to 4 carbon atoms, alkoxyl, halogen, trifluoromethyl group of 1 to 4 carbon atoms, R 2 means hydrogen, alkyl group of 1 to 4 carbon atoms, R 3 to R 7 represent an alkyl group having 1 to 4 carbon atoms which are the same as or different from each other, X, Y, and Z each represent 0 or 1, and n represents an integer of 1 to 3.
구조식(I) 화합물을 제조하는 방법은 영국특허 제1,342,547호, 일본 특허공개 제75-142533호, 대한민국 공개특허 제85-385호동에 보고되어 있으며, 대부분의 경우 구조식(II)의 산이나 그의 유도체와 구조식(III)의 알코올을 반응시켜 구조식(I)의 에스테르를 제조하였다.Methods for preparing the compound of formula (I) have been reported in British Patent No. 1,342,547, Japanese Patent Publication No. 75-142533, Korean Patent Publication No. 85-385, and in most cases, acids of the formula (II) or derivatives thereof. An ester of formula (I) was prepared by reacting an alcohol of formula (III).
상기 구조식에서 R1-R7및 x,y,z,n은 전술한 바와같다.Wherein R 1 -R 7 and x, y, z, n are as described above.
본 명세서에서 할로겐은 클로로 또는 브로모를 의미하며, 산의 유도체라 함은 에스테르 및 산 염화물을 의미한다. 구조식(II) 화합물의 에스테르를 사용하여 구조식(I) 화합물을 제조하는 예는 영국특허 제1,342,547호에 보고되어 있으며, 이 방법에 의하면 구조식(II) 화합물의 알킬에스테르를 촉매인 금속 알콕사이드의 존재하에 구조식(Ⅲ)의 알코올과 고온에서 반응시켜 구조식(I)의 에스테르를 제조하였다. 그러나 상기 방법은 반응온도가 높고, 수율이 낮은 결점을 갖고 있다.As used herein, halogen means chloro or bromo and derivatives of acid means esters and acid chlorides. An example of preparing the compound of formula (I) using esters of the compound of formula (II) is reported in British Patent No. 1,342,547, according to this method, in the presence of a metal alkoxide which catalyzes the alkyl ester of the compound of formula (II). The ester of formula (I) was prepared by reacting the alcohol of formula (III) at high temperature. However, this method has disadvantages of high reaction temperature and low yield.
구조식(II) 화합물의 산 염화물을 사용하여 구조식(I) 화합물을 제조한 예는 일본특허공개 제75-142533호에 보고되어 있는데, 이 방법에 의하면, 구조식(II) 화합물의 산 염화물을 제조하여 구조식(III)의 알코올과 반응시켜 구조식(I)의 에스테르를 제조하였다. 그러나 상기 방법은 에스테르 제소시에 반응시간이 길며 산 염화물이 불안정하다는 결점을 갖고 있다.An example of preparing the compound of formula (I) using an acid chloride of the compound of formula (II) is reported in Japanese Patent Laid-Open No. 75-142533. According to this method, an acid chloride of the compound of formula (II) An ester of formula (I) was prepared by reaction with an alcohol of formula (III). However, this method has the drawback that the reaction time is long and the acid chloride is unstable at the time of ester removal.
다음으로 축합제인 N,N'-디사이클로헥실카보디이미드를 사용하요 구조식(II)의 산과 구조식(III)의 알코올을 직접 반응시켜 구조식(I)의 에스테르를 제조한 예는 대한민국 공개특허 제85-385호에 나와있다. 그러나, 이 방법에서는 부산물로 생기는 N,N-디사이클로헥실우레아가 항상 불순물로 존재하며, 부반응(N-아실우레아의 생성)이 존재하기 때문에 수율이 낮은 결점이 있다.Next, N, N'-dicyclohexylcarbodiimide, which is a condensing agent, is used. An example of preparing an ester of the structural formula (I) by directly reacting an acid of the structural formula (II) with an alcohol of the structural formula (III) is disclosed in Korean Patent Application Publication 85. It is shown in -385. However, in this method, N, N-dicyclohexylurea produced as a by-product is always present as an impurity, and there is a disadvantage in low yield because of side reactions (production of N-acylurea).
본 발명은 구조식(VI)의 새로운 방응성 에스테르를 사용하여 구조식(I) 화합물을 제조하는 새로운 에스테르화 방법을 제공한다. 따라서, 본 발명의 목적은 구조식(IV)로 표시되는 1-하이드록시 벤조트리아졸과 구조식(V)의 디알킬(또는 디아릴) 클로로포스페이트(또는 클로치오포스페이트)를 3급아민의 존재하에 반응시켜 구조식(VI)의 중간체를 제조하고, 여기에 구조식(II)의 산을 방응시켜 구조식(VII)의 반응성 에스테르를 제조한 후, 이것을 구조식(III)의 알코올과 반응시켜 목적하는 구조식(I) 화합물을 제조하는 새로운 에스테르화 방법을 제공하는 것이다.The present invention provides a novel esterification process for preparing a compound of formula (I) using a novel reactive ester of structure (VI). Accordingly, an object of the present invention is to react 1-hydroxy benzotriazole represented by formula (IV) with dialkyl (or diaryl) chlorophosphate (or clociophosphate) of formula (V) in the presence of a tertiary amine. To prepare an intermediate of formula (VI), react the acid of formula (II) to prepare a reactive ester of formula (VII), and then react it with an alcohol of formula (III) to It is to provide a new esterification method for preparing a compound.
상기 구조식에서, R1-R7및 x,y,z,n은 전술한 바와같고, R은 에틸 또는 페닐기를 나타내고, X는 산소 또는 황원자를 나타낸다. 이들 방응중에서 중간체인 화합물(VI)을 제조하기 위한 용매로는 아세톤, 에틸아세테이트, 염화메틸렌, 클로로포름, N,N-디메틸포름아미이드, N,N-디메틸아세트아마이드, 디메틸설폭사이드, 테트라하이드로푸란등 위의 반응을 저해하지 않는 극성 용매이면, 알코올 종류를 제외하고는 모두 사용할 수 있다. 사용하는 3급아민에는 트리에틸아민, 트리메틸아민, 피리딘, N-메틸몰폴린등이 있으며, 이중 트리에틸아민이 가장 적합하다. 또한 1-하이드록시벤조트리아졸 1당량에 대해 3급아민은 0.5-5당량을 사용할 수 있으며, 바람직하게는 1-1.5당량을 사용한다.Wherein R 1 -R 7 and x, y, z, n are as described above, R represents an ethyl or phenyl group and X represents an oxygen or sulfur atom. The solvent for preparing compound (VI), which is an intermediate in these reactions, is acetone, ethyl acetate, methylene chloride, chloroform, N, N-dimethylformamide, N, N-dimethylacetamide, dimethyl sulfoxide, tetrahydrofuran As long as it is a polar solvent which does not inhibit the above reaction, all can be used except an alcohol kind. Tertiary amines to be used include triethylamine, trimethylamine, pyridine, N-methylmorpholine and the like, of which triethylamine is most suitable. The tertiary amine may also be used in an amount of 0.5-5 equivalents to 1 equivalent of 1-hydroxybenzotriazole, preferably 1-1.5 equivalents.
구조식(V) 화합물은 1-하이드록시벤조트리아졸 1당량에 대해 1 내지 1.5당량을 사용하며 구조식(V) 화합물의 대표적인 예로는 디에틸클로포스페이트, 디페닐클로로포스페이트, 디에틸크로로치오포스페이트, 디페닐클로로치오포스페이트등이 있다.The compound of formula (V) is used in the amount of 1 to 1.5 equivalents based on 1 equivalent of 1-hydroxybenzotriazole. Representative examples of the compound of formula (V) include diethyl chlorophosphate, diphenylchlorophosphate, diethyl chlorochlorothiophosphate, Diphenylchlorothiophosphate and the like.
반응은 0-50℃의 범위에서 행할 수 있으나, 통상 상온에서 실시하며 반응시간은 1-5시간, 바람직하게는 2시간이 소요된다. 반응이 끝나면 부생하는 염을 여과하여 제거하고 반응액중의 용매를 감압 증류하여 제거하면, 중간체인(VI) 화합물이 정량적으로 얻어진다.The reaction can be carried out in the range of 0-50 ° C, but is usually carried out at room temperature and the reaction time is 1-5 hours, preferably 2 hours. After the reaction, the by-product salts are filtered off, and the solvent in the reaction solution is distilled off under reduced pressure to obtain quantitative intermediate (VI).
다음으로 구조식(VII)의 반응성 에스테르를 제조하기 위한 용매로는 아세톤, 테트라하이드로푸란, N,N-디메틸아세트아마이드, N,N-디메틸아세트아마이드, 디메틸설폭사이드등 물과 잘 섞이는 극성용매이면 알코올 종류를 제외하고는 모두 사용할 수 있다.Next, as a solvent for preparing the reactive ester of the formula (VII), if it is a polar solvent mixed well with water such as acetone, tetrahydrofuran, N, N-dimethylacetamide, N, N-dimethylacetamide, dimethyl sulfoxide, You can use all but the kind.
반응은 통상 사온에서 진행되며 반응시간은 1내지 5시간이 소요되나 2시간 정도가 바람직하다. 반응이 완결되면 반응용액을 빙수에 분산시켜 부생하는 반응성 에스테르를 분말상태로 얻는다. 이때 사용되는 빙수의 양은 반응용액의 5-50배를 사용할 수 있으나. 10-15배가 가장 적합하다.The reaction is usually carried out at room temperature and the reaction time takes 1 to 5 hours, but preferably about 2 hours. When the reaction is completed, the reaction solution is dispersed in ice water to obtain byproduct reactive ester in powder form. The amount of ice water used at this time can be used 5-50 times the reaction solution. 10-15 times is most suitable.
다음으로 구조식(I)의 에스테르를 제조하기 위한 용매로는 N,N-디메틸포름아미이드, N,N-디메틸아세트아마이드, 디메틸설폭사이드, 아세톤, 테트라하이드로푸란등이 있으며, 이중 N,N-디메틸포름아미이드와 N,N-디메틸아세트아마이드가 가장 바람직하게 반응이 진행된다.Next, solvents for preparing the ester of the structural formula (I) include N, N-dimethylformamide, N, N-dimethylacetamide, dimethyl sulfoxide, acetone, tetrahydrofuran, and the like. Dimethylformamide and N, N-dimethylacetamide are most preferably reacted.
반응시간은 4-10시간이 소요되며, 상온에서는 통상 5-6시간이 소요된다. 반응이 완결되면 반응용액을 10-20배의 물에 분산시키고 유기용매로 추출한다음, 말레인산을 가하여 구조식(I)의 에스테르를 말레인산염으로 얻는다.The reaction time takes 4-10 hours, usually 5-6 hours at room temperature. When the reaction is completed, the reaction solution is dispersed in 10-20 times of water, extracted with an organic solvent, and then maleic acid is added to obtain an ester of formula (I) as maleate.
본 발명은 기존의 에스테르화 방법과 비교할때 다음과 같은 장점이 있다.The present invention has the following advantages compared to the conventional esterification method.
1. 중간체인 구조식(VII)의 방응성 에스테르는 기존의 산 염화물이나 혼합 산 무수물보다 안정하기 때문에, 분리하여 에스테르화 반응을 정량적으로 시킬 수 있으며, 2. 에스테르화 반응시 부반응이 진행되지 않으므로, 구조식(I) 화합물의 수율이 높으며, 3. 모든 반응이 상온에서 진행되므로, 반응시간이 비교적 짧고, 4. 중간체 제조에 사용되는 1-하이드록시벤조트리아졸은 회수하여 재사용이 가능하기 때문에, 기존의 방법보다 제조시설 및 공정이 간편하고 수율이 높으므로 새롭고도 경제적인 에스테르화 방법을 제공한다.1. Since the reactive ester of formula (VII), which is an intermediate, is more stable than conventional acid chlorides or mixed acid anhydrides, the esterification reaction can be separated quantitatively. 2. Since the side reactions do not proceed during the esterification reaction, The yield of the compound of formula (I) is high, and 3. the reaction time is relatively short, because all the reaction proceeds at room temperature, 4. the 1-hydroxybenzotriazole used for the preparation of the intermediate can be recovered and reused, The production facilities and processes are simpler and higher yield than the method of the present invention provides a new and economical esterification method.
다음의 실시예는 본 발명의 방법을 좀더 상세히 설명하기 위한 것이며, 이들 실시예가 본 발명을 제한하는 것은 아니다.The following examples are intended to illustrate the method of the present invention in more detail, and these examples do not limit the present invention.
[실시예 1]Example 1
1-하이드록시벤조트리아졸 6.75kg(0.05M)을 아세톤 50ml에 혼탁시키고 트리에틸아민 7.66g(0.055M)을 서서히 가하여 완전히 녹인다. 용액의 온도를 5-10℃로 유지하면서 디에틸클로로포스페이트 7.23ml(0.05M)를 10분간에 걸쳐서 적가한다음 전기한 온도에서 1시간동안 교반해준다. 생성된 불용물은 여과하여 제거하고 여액은 다음 반응에 사용한다.6.75 kg (0.05 M) of 1-hydroxybenzotriazole is turbid in 50 ml of acetone, and 7.66 g (0.055 M) of triethylamine is slowly added to dissolve completely. 7.23 ml (0.05 M) of diethylchlorophosphate was added dropwise over 10 minutes while maintaining the temperature of the solution at 5-10 ° C. and stirred for 1 hour at the temperature mentioned above. The resulting insolubles are filtered off and the filtrate is used for the next reaction.
3,4,5-트리메톡시벤조익산 10.6g(0.05M)을 트리에틸아민 6.97ml(0.05M) 및 N,N-디메틸포름아마이드 20ml의 용액에 완전히 녹인후, 여기에 위에서 제조한 아세톤 용액을 30분에 걸쳐서 적가한다. 이때 반응온도는 15-20℃가 적합하다.10.6 g (0.05 M) of 3,4,5-trimethoxybenzoic acid was completely dissolved in a solution of 6.97 ml (0.05 M) of triethylamine and 20 ml of N, N-dimethylformamide, followed by the acetone solution prepared above. Add dropwise over 30 minutes. The reaction temperature is preferably 15-20 ℃.
계속하여 2시간 교반하여 반응을 완결시키고, 반응용액을 700ml의 빙수에 혼탁시킨다. 결정이 생성되면 계속하여 30분간 교반해주고 여과한다음 빙수 50ml×2회 세척해주고 건조하면 목적하는 3,4,5-트리메톡시벤조익산의 1-하이드록시벤조트리아졸 에스테르 15.6g(95%)을 얻는다.Then, the mixture was stirred for 2 hours to complete the reaction, and the reaction solution was turbid in 700 ml of ice water. After the crystals were formed, the mixture was stirred for 30 minutes, filtered, and then washed with 50 ml of ice-water twice, and when dried, 15.6 g (95%) of 1-hydroxybenzotriazole ester of the desired 3,4,5-trimethoxybenzoic acid. Get
mp(℃) : 160-170(분해)mp (℃): 160-170 (decomposition)
IR(KBr, cm-1) ; 2920(s),1790(VS, 에스테르카르보닐), 1595(VS),1500(VS),1460(VS),1320(VS)1H-NMR(CDCl3/TMS,) : 4.02(6H,s,4.10 (3H, S,, 7.57(2H,S,-, 7.48.3(4H,m, 벤조트리아졸-H)IR (KBr, cm-One) ; 2920 (s), 1790 (VS, estercarbonyl), 1595 (VS), 1500 (VS), 1460 (VS), 1320 (VS)OneH-NMR (CDCl3/ TMS,): 4.02 (6H, s,4.10 (3H, S,, 7.57 (2H, S,-, 7.48.3 (4H, m, benzotriazole-H)
[실시예 2]Example 2
아세톤 대신에 N,N-디메틸포름아마이드 50ml를 사용하여 실시예 1의 방법으로 반응을 시켜서, 목적하는 3,4,5-트리메톡시벤조익산의 1-하이드록시벤조트리아졸에스테르 15.3g(93%)을 얻는다.The reaction of Example 1 was carried out using 50 ml of N, N-dimethylformamide instead of acetone, and 15.3 g of 1-hydroxybenzotriazole ester of the desired 3,4,5-trimethoxybenzoic acid (93 %)
mp, IR 및1H-NMR 데이타는 실시예 1과 동일함.mp, IR and 1 H-NMR data are the same as in Example 1.
[실시예 3]Example 3
디에틸클로로포스페이트 대신에 디페닐클로로포스페이트 10.36ml(0.05M)를 사용하여 실시예 1의 방법으로 반응을 시켜서, 목적하는 3,4,5-트리메톡시벤조익산의 1-하이드록시벤조 트리아졸에스테르 15.8g(96%)을 얻는다.The reaction of Example 1 was carried out using 10.36 ml (0.05 M) of diphenylchlorophosphate instead of diethylchlorophosphate, thereby yielding 1-hydroxybenzotriazole of the desired 3,4,5-trimethoxybenzoic acid. 15.8 g (96%) of ester are obtained.
mp, IR 및1H-NMR 데이타는 실시예 1과 동일함.mp, IR and 1 H-NMR data are the same as in Example 1.
[실시예 4]Example 4
디에틸클로로포스페이트 대신에 디에틸클로로오포스페이트 7.86ml(0.05M)를 사용하여 실시예 1의 방법으로 반응을 시켜서, 목적하는 3,4,5-트리메톡시벤조익산의 1-하이드록시벤조트리아졸에스테르 14.8g(90%)을 얻는다.The reaction of Example 1 was carried out using 7.86 ml (0.05 M) of diethylchloroophosphate instead of diethylchlorophosphate, thereby yielding 1-hydroxybenzotria of the desired 3,4,5-trimethoxybenzoic acid. 14.8 g (90%) of sol esters are obtained.
mp, IR 및1H-NMR 데이타는 실시예 1과 동일함.mp, IR and 1 H-NMR data are the same as in Example 1.
[실시예 5]Example 5
2-디메틸아미노-2페닐부탄올염산염 4.66g(0.02M)을 N,N-디메틸 포름아마이드 150ml에 혼탁시키고 트리에틸아민 6.0ml(0.04M)을 서서히 가한다. 30분간 교반해준 후 실시예 1에서 제조한 3,4,5-트리메톡시벤조익산의 1-하이드록시 벤조트리아졸에스테르 6.69g(0.02M)을 고체상태로 가한다. 상기 용액을 15-20℃에서 5시간 교반해주면 반응이 완결된다. 반응용액을 21의 빙수에 서서히 가하고, 에틸아세테이트(200ml×3)로 추출한다. 에틸아세테이트 층을 빙수(100m1×2), 2% 탄수수소나트륨 수용액 (50ml×2)로 세척하여 용매를 감압 증류한다.4.66 g (0.02 M) of 2-dimethylamino-2phenylbutanol hydrochloride are turbid in 150 ml of N, N-dimethyl formamide and 6.0 ml (0.04 M) of triethylamine are added slowly. After stirring for 30 minutes, 6.69 g (0.02 M) of 1-hydroxy benzotriazole ester of 3,4,5-trimethoxybenzoic acid prepared in Example 1 was added in a solid state. The solution is stirred at 15-20 ° C. for 5 hours to complete the reaction. The reaction solution is slowly added to 21 ice water and extracted with ethyl acetate (200 ml x 3). The ethyl acetate layer was washed with ice water (100m1x2) and 2% aqueous sodium carbohydrate solution (50mlx2) to distill the solvent under reduced pressure.
잔류물에 에탄올 40ml와 말레인산 7.5g을 가하여 완전히 용액시킨 후 계속하여 교반해주면 결정이 석출되기 시작한다. 상온에서 2시간 0-5℃에서 2시간동안 교반한 다음 여과하면 백색 결정인 3',4',5'-트리메톡시벤조익산의 2-디메틸아미노-2-페닐부틸에스테르를 말레인산염으로 얻는다.40 ml of ethanol and 7.5 g of maleic acid were added to the residue, followed by complete solution and stirring. The crystals began to precipitate. After stirring for 2 hours at 0-5 ° C. at room temperature, the mixture was filtered to obtain 2-dimethylamino-2-phenylbutyl ester of 3 ', 4', 5'-trimethoxybenzoic acid as white crystals. .
수율 : 7.76g(82%)Yield: 7.76 g (82%)
mp(℃) : 129-130mp (℃): 129-130
IR(KBr, cm-1) : 2950(m),1720(VS,에스테르카르보닐), 1590(s), 1450(VS), 1330(VS), 1210(Vs)IR (KBr, cm -1 ): 2950 (m), 1720 (VS, ester carbonyl), 1590 (s), 1450 (VS), 1330 (VS), 1210 (Vs)
1H-NMR(CDCl3/TMS,) : 1.00(3H, t, J=8Hz,-CH2-CH3),2.65(2H,9,J=8Hz,-CH2-CH3),2.92 1 H-NMR (CDCl 3 / TMS, ): 1.00 (3H, t, J = 8Hz, -CH 2 -CH 3 ), 2.65 (2H, 9, J = 8Hz, -CH 2 -CH 3 ), 2.92
[실시예 6]Example 6
N,N-디메틸포름아마이드 대신에 N,N-디메틸아세트아마이드 150ml를 사용하여 실시예의 5의 방법으로 반응을 시켜서, 목적하는 3', 4', 5'-트리메톡시벤조익산의 2-디메틸아미노-2-페닐부틸에스테르를 말레인 산염으로 얻는다.Reaction was carried out by the method of Example 5 using 150 ml of N, N-dimethylacetamide instead of N, N-dimethylformamide, and 2-dimethyl of the desired 3 ', 4', and 5'-trimethoxybenzoic acid. Amino-2-phenylbutyl ester is obtained as maleic acid salt.
수율 : 7.38g(78%)Yield: 7.38 g (78%)
mp,IR 및 H-1NMR 데이타는 실시예 5와 동일함.mp, IR and H- 1 NMR data are the same as in Example 5.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019850002939A KR890001851B1 (en) | 1985-05-01 | 1985-05-01 | Process for the preparation of amine alkanolester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019850002939A KR890001851B1 (en) | 1985-05-01 | 1985-05-01 | Process for the preparation of amine alkanolester |
Publications (2)
Publication Number | Publication Date |
---|---|
KR860008969A KR860008969A (en) | 1986-12-19 |
KR890001851B1 true KR890001851B1 (en) | 1989-05-27 |
Family
ID=19240718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850002939A KR890001851B1 (en) | 1985-05-01 | 1985-05-01 | Process for the preparation of amine alkanolester |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR890001851B1 (en) |
-
1985
- 1985-05-01 KR KR1019850002939A patent/KR890001851B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR860008969A (en) | 1986-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4471137A (en) | Highly sterically hindered guanidines and process for the production thereof | |
US6197998B1 (en) | Process for producing N-glycyltyrosine and its crystal structure | |
EP0099960B1 (en) | Process for the preparation of lower alkyl esters of n-l-alpha-aspartyl-l-phenyl alanine, and intermediates for their manufacture | |
KR890001851B1 (en) | Process for the preparation of amine alkanolester | |
KR0163599B1 (en) | Preparation of 2-alkylthio-1,3,4-thiadiazoles | |
JPH07116126B2 (en) | 2,3-diaminoacrylonitrile derivative | |
US4491548A (en) | Process for preparing phosphonomethylated amino acids | |
PL141866B1 (en) | Method of obtaining 1,8-dihydroxy-10-ocyl-9-antrones | |
JPH0737440B2 (en) | Method for producing sulfonium compound | |
JP3046258B2 (en) | Method for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof | |
US4548760A (en) | Process for preparing phosphonomethylated amino acids | |
JPS61218555A (en) | Manufacture of acids substituted with trifluorodichloroethylgroup and zinc compounds | |
EP0088252B1 (en) | Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolacetoxy-acetic acid | |
KR930006198B1 (en) | Novel alpha-chloroketone derivative and process for preparation thereof | |
US5220041A (en) | Sulfonate ester | |
EP0087656B1 (en) | Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolylacetoxy-acetic acid | |
JPS61112056A (en) | Imidazole derivative and production thereof | |
KR850001698B1 (en) | Process for the preparation of 2-dialkylamino-2-phenyl-n-buthyl-3',4',5'-trimethoxybenzoic derivatives | |
KR100348100B1 (en) | Manufacturing method of 2-[(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid | |
KR100498894B1 (en) | Process for producing 1-chlorocarbonyl-4-piperidino- piperidine or hydrochloride thereof | |
JPS62267267A (en) | Pyrazole derivative and production thereof | |
CH657124A5 (en) | 3-Chloroisocinchomeronoyl chloride and a process for its preparation | |
PL164340B1 (en) | Method of obtaining novel benzothiazine derivatives | |
KR810001172B1 (en) | Process for preparing n2-substituted-2,6-diaminonebularines | |
KR920003690B1 (en) | Process for preparation of quinoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20040115 Year of fee payment: 16 |
|
EXPY | Expiration of term |